Polyunsaturated fatty acids (PUFAs) are important constituents of the diet and health benefits of omega-3/n À 3 PUFAs, especially eicosapentaenoic acid (EPA, 20:5 n À 3) and docosahexaenoic acid (DHA, 22:6 n À 3) have been well documented in relation to several diseases. Increasing evidence suggests that n À 3 PUFAs may have anticancer activity and improve the effect of conventional cancer therapy. The mechanisms behind these effects are still unclear and need to be elucidated.
Introduction
Several epidemiological studies have pointed to a positive correlation between dietary fish intake and the reduced risk of developing age related disorders such as circulatory disturbances, neurodegenerative diseases, and different types of cancer [1] [2] [3] . The disease preventive effects of increased fish intake have been associated with the content of omega-3 (n-3) polyunsaturated fatty acids (PUFAs) present in marine species [4] . Case-control studies have suggested an inverse correlation between dietary fish intake and colorectal cancer [5, 6] . n À3 PUFAs have been shown to inhibit growth of human cancer cells in culture and when grafted in mice [7, 8] . Several mechanisms have been proposed to explain the anticancer activity mediated by n À 3 PUFAs like increased oxidative stress, lipid peroxidation, modulation of cyclooxygenase activity and changes in membrane phospholipid composition and receptor function [9] [10] [11] . However, why some cancer cells die and others survive when exposed to n À 3 PUFAs is still poorly defined.
We have previously shown that docosahexaenoic acid (DHA, 22:6n À 3) induces endoplasmic reticulum (ER) stress, unfolded protein response (UPR) and growth arrest in several human cancer cell lines [12] [13] [14] . Increased protein levels of PKR-like ER kinase (PERK)-mediated phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2α), indicative of ER stress, were found at early time points [14] . The main functions of the ER are protein synthesis and folding, maintenance of calcium homeostasis and lipid synthesis. Interference with any of these processes may lead to ER-stress and activation of UPR in order to restore cellular homeostasis. The activation of UPR is followed by attenuation of protein translation and activating transcription factor 4 (ATF4) mediated up-regulation of genes to ensure cell survival or to mediate cell death when stress is too severe.
Recently, it has become clear that induction of ER stress as well as several other forms of cellular stress like nutrient deprivation, reactive oxygen species (ROS), DNA damage, protein aggregates and damaged organelles may lead to the induction of autophagy as reviewed in [15] . Macroautophagy (hereafter referred to as autophagy) is a catabolic process that removes damaged cellular components to maintain cellular integrity and stability [16] . During the autophagic process, cytoplasmic proteins and organelles are sequestered by a growing double membrane that forms an autophagosomal vesicle, and the content is degraded after fusion with a lysosome. A basal activity of autophagy is needed to maintain normal cellular homeostasis, and the level of activity may be increased in response to different kinds of stresses [17, 18] . Dysregulation of this process is linked to different conditions like neurodegeneration, aging, cancer, and infectious-, cardiovascularand metabolic diseases. In cancer, autophagy has dual roles by acting both as a tumor suppressor preventing initiation of tumorigenesis, but also by assisting cancer cells in coping with stressful conditions thereby promoting cancer cell growth [19] . Autophagy is a highly evolutionary conserved process that is regulated by autophagy-related genes (ATGs) [20] . The ATG 1/Unc-51-like kinase 1/2 (ULK1/2 kinase) is considered a principal regulator of autophagy [21] . The ULK1/2 kinase activity and its ability to stimulate autophagy is negatively regulated by the mammalian target of rapamycin complex 1, mTORC1 [22] . When activated, mTOR inhibits autophagy by phosphorylation of ULK1 [23] . The tumor suppressors 5′ AMP-activated protein kinase (AMPK), phosphatase and tensin homolog (PTEN), liver kinase B1 (LKB1) and tuberous sclerosis 1/2 (TSC1/2) positively regulate autophagy both by inhibiting mTOR and by activating the ULK1/2 activity directly [21] . ATF4 also regulates mTOR activity negatively via transcriptional up-regulation of DNA-damage-inducible transcript 4 (REDD1) [24] . During ER stress, the PERK-eIF2α-ATF4 branch of UPR is required for increased expression of REDD1. ER stress may also lead to the production of ROS and vice versa; it is however not clear whether oxidative stress is involved in autophagy mediated by ER stress.
The redox-sensitive transcription factor nuclear factor erythroid-2-related factor-2 (NFE2L2/Nrf-2) regulates the expression of genes involved in the endogenous antioxidant response [25] . In unstressed conditions, NFE2L2 is distributed in the cytoplasm in association with kelch like-ECH-associated protein 1 (KEAP1), a protein essential for the regulation of NFE2L2 activity through degradation via the ubiquitin-proteasome system [26] . When stress is induced, NFE2L2 is phosphorylated and dissociates from KEAP1 and translocates to the nucleus where it activates target genes involved in the antioxidant defense or phase II detoxification through interaction with the antioxidant response element (ARE) [27] . NFE2L2 has also been shown to be a direct substrate for the PERK kinase activity. Upon ER stress, PERK phosphorylates NFE2L2 to promote dissociation from KEAP1 and translocation to the nucleus [28] . The sequestosome 1 protein (SQSTM1/p62) is a scaffold protein involved in clearance of ubiquitinated protein aggregates and organelles through selective autophagy [29, 30] . The promoter of SQSTM1 contains an ARE-element and transcription of SQSTM1 is thus regulated by NFE2L2 [31] . SQSTM1 has also been shown to interact with KEAP1 at the NFE2L2 binding site, leading to NFE2L2 release and translocation to the nucleus thereby contributing to a positive feedback regulation of selftranscription [32] .
The signaling pathways of ER stress, oxidative stress and autophagy are complex and seem to be interrelated. We have previously shown by gene expression profiling that treating the human colon cancer cell line SW620 with the nÀ 3 PUFA DHA increases the level of transcripts involved in ER stress and NFE2L2 target transcripts like heme oxygenase 1 (HMOX1), glutamate-cysteine ligase modifier (GCLM), thioredoxin reductase 1 (TXNRD1) and SQSTM1 [14] . In this study we explore whether oxidative stress and/or autophagy could be involved in modulating the cytotoxic effect of DHA in human colon cancer cell lines.
We here report that oxidative stress-and autophagy-related transcripts are among the primary response genes to DHA in SW620 colon cancer cells. Vitamin E did not counteract DHA-induced ROS, did not interfere with nuclear translocation of NFE2L2 and did not restore cell growth in SW620 cells. SiRNA-mediated down-regulation of NFE2L2 did not sensitize Caco-2 cells to DHA. These results indicate that oxidative stress is not the cause of DHAinduced cytotoxicity in SW620 cells. Even though several autophagy related genes are induced in the sensitive SW620 cells in response to DHA, no evident activation of the autophagy process could be observed in these cancer cells. Inhibition of autophagy by siRNA mediated knock down of ATG5 and ATG7 sensitized both SW620 and Caco-2 cells to DHA while stimulating autophagy in both cell lines by inhibiting mTOR resulted in decreased DHA sensitivity.
Our results indicate that the basal level of autophagy is important for surviving the cellular stress induced by DHA and suggest that colon cancer cells with low basal autophagy are more sensitive to stress and may be targeted by DHA.
Materials and methods

Cell cultures and reagents
SW620 and Caco-2 cells were obtained from American Type Culture Collection (ATCC) (Rockville, MD). SW620 cells were cultured in Leibovitz's L-15 medium (#BE-12-700, Lonza, Basel, Switzerland), supplemented with L-glutamine (#17-605E, Lonza, 2 mM), Fetal Bovine Serum (FBS, 10270, Gibco, 10%) and Gentamicin (#15710049, Gibco, 0.05 mg/ml). Caco-2 cells were cultured in Eagle medium (#M5650, Sigma-Aldrich) supplemented with L-glutamine (#17-605E/ Lonza, 2 mM), Sodium pyruvate (#P5280, Sigma-Aldrich, 1%), Gentamicin (0.05 mg/ml), and FBS (20%). Cells were maintained in a humidified atmosphere of 5% CO 2 ; 95% air at 37°C. 4,7,10,13,16,19-docosahexaenoic acid (DHA) and 9-octadecanoic acid (OA) were obtained from Cayman Chemical (Ann Arbor, MI) as solutions in ethanol. Vitamin E ( 7-α-tocopherol, T3251), Butylated hydroxyanisole (BHA, B1253), Butylated hydroxytoluene (BHT, B1378), Rapamycin (R8781), Bafilomycin A1 (BafA1, B1793), Chloroquine (Chl, C6628) and Hanks' Balanced Salt Solution (HBSS, #H8264) were obtained from Sigma-Aldrich (St. Louis, MO).
The following primary antibodies were used: Specific to SQSTM1 (#GP-62-C, Progen Biotechnik); NFE2L2 (#sc-13032, H-300, Santa Cruz Biotechnology, Inc. and #12721, D1Z9C, Cell Signaling Technologies); LC3B-II (#3868, D11, Cell Signaling Technologies); HMOX1 (#ADI-OSA-110, Stressgen); BAG3 (#ab47124, Abcam); HSPA1A (#SPA-810, Stressgen), ACTB (#ab6276, AC-15, Abcam); TUBB (#ab6046, Abcam); COX IV (#ab33985, Abcam and #926-42214, Li-cor Biotechnology, Inc), KEAP1 (#sc-15246, E20, Santa Cruz Biotechnology, Inc), TRIB3 (#HPA015272, Sigma Aldrich). All secondary antibodies were from Molecular Probes (Alexa conjungates) or Li-Cor Biotechnology (NIR dye conjungates).
Fatty acid supplementation and survival assays
Stock solutions of fatty acids in ethanol were stored at À 20°C and further diluted in complete growth medium with FBS before experiments, such that the final concentration of ethanol was o0.025% (v/v). DHA/OA/BafA1-treatments were initiated 24 h after cell seeding. MTT-assay was performed as previously described [12] .
Cell proliferation was also monitored in real time using the xCELLigence RTCA DP instrument (ACEA Biosciences Inc.) according to the supplier's recommendations. Where indicated, the cells were pretreated with 50 nM rapamycin for 30 min before adding fresh medium containing vehicle or DHA. For inhibition of autophagy, chloroquine (10 mM) was added alone or in combination with DHA (70 mM). For starvation, total L-15 medium was diluted with 50% HBSS.
Gene expression profiling
SW620 cells were treated with vehicle (ethanol) or 70 mM DHA for 30 min, 1, 3, 6, 24 and 48 h before RNA isolation. Expression profiling was performed in triplicates at all time points, except for 1 h, where one control array was excluded. The statistical analysis was based on summary expression measures using the raw data (CEL) files performed by the robust multiarray average method as previously described [14, 33] . The statistical analysis was performed in R (http://www.r-project.org), using packages Limma and Affy from Bioconductor. Differentially expressed genes were selected based on a threshold of 0.05 on the adjusted P values. All data have been submitted to ArrayExpress with the accession numbers E-MEXP-2010 (30 min, 1, 3, 6 h) and E-MEXP-1014 (12, 24, 48 h).
siRNA mediated knock down and transient transfection
For NFE2L2 down regulation, Caco-2 cells and SW620 cells were transfected using 10-20 nM and 50 nM siRNA (final concentrations), respectively and DharmaFECT transfection reagent 1 (Dharmacon) diluted in Optimem 1 Reduced Serum Medium (#31985-070, Gibco Life Technologies). Following 24 h, the cells were collected by trypsination and seeded for real-time cell monitoring, cell counting and immunoblot analysis. The following siRNA oligonucleotides were obtained from Dharmacon; non-targeting siRNA (D-001210-01); NFE2L2 siRNA (D-003755-02, target sequence: 5′-CCAAAGAGCAGUUCAAUGA); ATG5 (L-004374-00) and ATG7 (L-020112-00), SQSTM1 (J-010230-06-0020, target sequence 5′-GCAUUGAAGUUGAUAUCGA) and HMOX1 (D_006372-05-0050, target sequence: 5′-GGCAGAGGGUGAUAGAAGA). Allstars negative control siRNA (#1027280) and Allstar HS Cell Death Control siRNA (#1027298) were obtained from Qiagen.
The double tag mCherry-EGFP [30] was transfected into the cells using X-treme GENE HP DNA Transfection Reagent (Roche) following the supplier's recommendations. After transfection, cells were seeded in wells with cover-glass bottom, left for 24 h before adding vehicle or DHA for 16 h. Cells were fixated using 4% paraformaldehyde in PBS (pH 7.2) for 10 min and stored in PBS until confocal microscope imaging. The number of punctuated green and red structures per cell was determined in more than 100 cells per condition per experiment.
Detection of ROS and lipid peroxidation
ROS production was determined using the Image-iT ™ LIVE Green Reactive Oxygen Species Detection Kit (DCF, Molecular Probes) and a BD FACS Canto flow cytometer (BD Biosciences) in SW620 and Caco-2 cells. As a positive control, 100 mM tert-butyl hydroperoxide (TBHP) was added 80 min before intracellular ROS was determined. Mitochondrial superoxide production was determined using 5 mM MitoSOX TM Red (Molecular Probes) mitochondrial superoxide indicator. Lipid peroxidation in Caco-2 cells was measured as the secondary lipid peroxidation product malondialdehyde (MDA) using the OxiSelectTM TBARS Assay Kit (Cell Biolabs, INC). Caco-2 cells were treated with vehicle, DHA (70 mM), vitamin E (50 mM) or cotreated with DHA (70 mM) and vitamin E (50 mM) for 72 h before scraping in ice cold PBS and frozen in aliquots of 20 Â 10 6 cells/ml.
MDA reacts with thiobarbituric acid (TBA) resulting in thiobarbituric acid reactive substances (TBARS) that are measured colorimetrically.
Cellular localization of autophagy biomarkers and NFE2L2
Subcellular localization of SQSTM1, NFE2L2 and LC3B was determined by immunostaining and visualization by fluorescently labeled secondary antibodies. Immunostaining was imaged by an Axiovert200 microscope equipped with a 63 Â 1.2W objective and the confocal module LSM510 META (Carl Zeiss). Images were processed using the LSM software (Carl Zeiss) and mounted using Canvas 11 (ACD Systems). Images are representative of more than 200 randomly selected cells in each condition and of two or more independent experiments. Cytoplasmic structures enriched for LC3 were quantified by using the histogram function in the LSM software. All images were taken with the same settings. Pixels positive for LC3B with an intensity of more than 100 RLU were counted and divided by the number of cells in the image (more than 100 cells per condition).
Autophagy determined by flow cytometry
Autophagic structures were determined using the CytoID autophagy detection kit following the suppliers' instructions (Enzo Life Sciences). Briefly, the cells were detached by trypsination and stained in a solution with Cyto-ID Detection Reagent covered from light for 30 min at room temperature with gentle rotation, and the fluorescent intensity per cell was determined using a flow cytometer.
Immunoblotting
Cells, transfected or non-transfected, untreated or treated with DHA and/or 100 nM BafA1, were harvested by trypsinization or scraped in ice cold PBS. Cells were lysed in either a buffer containing 1% NP40, 0.25% Triton-X100, 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA pH 8, Complete s protease inhibitor (PI, Roche), and phosphatase inhibitor cocktail I and III (Sigma-Aldrich), or an urea buffer containing 8 M Urea, 0.5% (v/v) Triton X-100, 100 mM DTT, PI, and phosphatase inhibitor cocktail I and III. Total protein concentration in the lysates was determined by Bio-Rad protein assay (Bio-Rad). Bound antibodies were imaged by near infrared fluorescence using appropriate fluorescent dye labeled secondary antibodies and an Odyssey NIR scanner (Li-Cor Biosciences). Images were processed using the Li-Cor Odyssey software and mounted using the Canvas 11 software (ACD Systems).
Results
DHA induces changes in expression of genes involved in oxidative stress, protein folding and autophagy at early time points
The effect of DHA on cell growth/cell index of the colon cancer cell lines SW620 and Caco-2 was determined by MTT assay and real time analysis (xCELLigence System), respectively ( Fig. 1) . The effect on cell growth/cell index measured by both systems corresponded well. We found that DHA reduced growth of SW620 cells in a time-and concentration-dependent manner, as measured by the MTT assay. Cell viability started to decline after approximately 24 h supplementation with DHA (70 mM) in SW620 cells; a 30% and 50% reduction in cell viability could be observed after 48 and 72 h, respectively. The cell growth/cell index of Caco-2 cells were almost unaffected by the same treatment. Supplementation of SW620 cells with the monounsaturated fatty acid oleic acid (OA) (18:1, n À 9) did not result in any change in cell index relative to control cells. The relative differences in response to DHA were verified by conventional cell counting (data not shown). The rapid growth retardation after supplementation with DHA in SW620 cells suggest that relevant gene expression changes could occur very early.
We have previously performed gene expression analysis of SW620 cells after treatment with DHA (70 mM) or vehicle for 0.5, 1, 3, 6, 12, 24 and 48 h. No significant changes in gene expression were observed until 3 h after DHA supplementation [33] . At 3 h, 21 transcripts were found differentially expressed; 17 of these were upregulated, whereas 5 were down-regulated (data not shown). Among the earliest DHA-responsive transcripts was SQSTM1 (Table 1). The autophagy cargo receptor SQSTM1 physically links misfolded, ubiquitinated proteins to ATG8-family members located on the forming autophagosomal membrane [29, 30] . At 3 h, we also identified increased mRNA levels of the Bcl2-associated athanogene 3 (BAG3), as well as the chaperones Heat shock protein 40 (Hsp40) and Hsp70, the oxidative stress response gene HMOX1 and the ER stress response gene REDD1. After 6 h with DHA, 16 of the 21 transcripts were still differentially expressed. Moreover, an increased number of transcripts were differentially expressed at 6 h; 859 were up-regulated and 587 were down-regulated. The immediate activation of SQSTM1 and BAG3 may suggest induction of autophagy as a primary transcriptional response to DHA. In line with this, several ATG transcripts, including microtubule-associated protein 1 light chain 3 beta (LC3B) and its homologs GABA(A) receptor-associated protein like 1 (GABARAP-L1 and -L2), ATG14, as well as the autophagy regulators ULK1, sestrin 2 (SESN2) and Tribbles homolog 3 (TRIB3) were found to be significantly up-regulated (po0.05) after 6 h DHA-treatment. Previous obtained gene expression data of SW620 cells treated with DHA for longer periods of time (12, 24 and 48 h) [14] also revealed increased mRNA levels of ATG12, BCL2/ adenovirus E1B 19 kDa interacting protein 3-like (Bnip3L/Nix), and phosphoinositide-3-kinase class 3 (Vps34). For complete lists of Results from gene expression analyses were verified by measuring protein levels of selected targets (SQSTM1, HSPA1A, HMOX1, TRIB3 and BAG3) in SW620 and Caco-2 cells after DHAtreatment for 3-48 h (Fig. 2) . These analyses demonstrated a correlation between increased mRNA and protein level for these gene products. The protein level of SQSTM1, HSPA1A, HMOX1 and BAG3 increased with time up to 24 h in SW620 cells, while the same transcripts were much less affected in Caco-2 cells, except for HMOX1. HMOX1 was found expressed in Caco-2 control cells, and increased with time up to 12 h, followed by a decrease at 24 and 48 h. HMOX1 was not expressed in SW620 control cells, but was found expressed after 6 h treatment with DHA. The expression increased up to 24 h and to a higher extent when compared to Caco-2 cells, before decreasing at 48 h. Controls were harvested at all times points, only 24 h control is shown and set to 1. Results were verified in three independent experiments; one representative blot is shown. Protein band intensities, normalized against ACTB are displayed and represent mean fold change (SD) of DHA samples relative to control at the indicated time points for three independent experiments. *Significantly different from control at the same time point (student's t-test, p o0.05). 3.2. DHA induces a rapid increase in cellular ROS and nuclear import of NFE2L2 in the SW620 colon cancer cells HMOX1 and SQSTM1 have previously been found to be induced by ROS via activation of the transcription factor NFE2L2 [34] . In the DHAsensitive SW620 cells, an increase in ROS was observed already after 3 h of DHA-supplementation and a further increase was observed up to 24 h (Fig. 3A) . Similarly, a clear increase in mitochondrial superoxide was detected in response to DHA in SW620 cells (Fig. 3B) . However, the antioxidant vitamin E was not able to counteract DHAinduced formation of ROS in SW620 cells (Fig. 3C ) and had no effect on cell survival (data not shown). Also, the two antioxidants BHA and BHT were not able to counteract the growth-inhibitory effect of DHA in SW620 cells (data not shown). In line with this, vitamin E supplementation did not interfere with DHA-induced nuclear translocation of NFE2L2 in these cells (data not shown). In contrast, the ROSlevel in Caco-2 cells was elevated only after prolonged treatment (24 h) of DHA when using the superoxide probe and to a much lesser extent (not significant). We therefore measured the level of malondialdehyde (MDA), a secondary product of lipid peroxidation, in Caco-2 cells after treatment with DHA alone or in combination with vitamin E (50 mM) for 72 h (Fig. 3D) . A several fold increase in the MDA level was observed in Caco-2 cells after DHA treatment (70 mM) for 72 h compared to control cells. Co-treatment with DHA (70 mM) and vitamin E (50 mM) reduced the level of MDA, but not to the same level as in control cells (Fig. 3D) . We have previously measured the level of MDA in SW620 cells under the same conditions [12] . The level of MDA was increased several fold in SW620 cells after treatment with DHA (70 mM) and a combinatory treatment with vitamin E (50 mM) reduced the level of MDA even below that in control cultures. These results indicate that oxidative stress and lipid peroxidation are induced by DHA-supplementation in both cell lines, although to different extents and at different time-points. NFE2L2 is a major regulator of transcription of antioxidant related genes. We determined the total protein level of NFE2L2 by immunostaining and found a significant higher level of NFE2L2 in SW620 cells as compared to Caco-2 cells (Fig. 4B) . A clear nuclear translocation of NFE2L2 could be observed in the SW620 cells after 6 h of DHA treatment by confocal imaging (Fig. 4A) , at the same time as we observed accumulation of SQSTM1 protein (Fig. 2A) . Even though ROS could not be detected at early time points in Caco-2 cells, an increased nuclear translocation of NFE2L2 in the Caco-2 cells could be observed after 6 h treatment (Fig. 4A) . These results indicate that the antioxidant defense system is activated in both cell lines after DHA-supplementation. Also, the level of KEAP1, a negative regulator of NFE2L2, was found lower in Caco-2 cells compared to SW620 cells (Fig. 4C) . Together, these results demonstrate that NFE2L2 is translocated to the nucleus in both SW620 and Caco-2 cells, but that the level of ROS induction and growth retardation in response to DHA is clearly different between the two cell lines.
Basal autophagy is low and not induced by DHA in SW620 colon cancer cells
To determine whether DHA could affect autophagy, the autophagy biomarkers LC3B and SQSTM1 were immunostained. The number of LC3B punctuated structures per cell as well as LC3B-SQSTM1 double positive structures was found to be clearly higher in Caco-2 control cells compared to SW620 control cells (Fig. 5A) . By adding bafilomycin A1 (BafA1) to inhibit lysosomal degradation, a clear increase in both the number of punctuated structures positive for LC3B per cell and the number of SQSTM1-LC3B double-positive structures could be observed in both cell lines, although to a much larger extent in Caco-2 cells. These results suggest a higher basal autophagy in Caco-2 cells as compared to SW620 cells. DHA treatment did not significantly change the number LC3B punctuated structures in any of the two cell lines, suggesting that there is no induction of autophagy in response to DHA supplementation in these colon cancer cell lines. On the other hand, amino acid starvation of SW620 cells for 3 h caused an increase in the number of pixels positive for LC3B and of cytosolic structures positive for both LC3B and SQSTM1 (Fig. 5B) . Combining amino acid starvation and inhibition of lysosomal degradation resulted in a synergistic raise in the number of autophagic structures positive for both proteins, indicating that autophagy may be induced in these cells, given the appropriate stimuli.
Autophagic flux was further analyzed by LC3B and SQSTM1 immunoblots of SW620 and Caco-2 cell extracts after treatment with DHA from 2 to 16 h in the absence or presence of BafA1 (Fig. 5C ). Analyzing LC3B-II protein level indicated no increase in autophagic flux by DHA-supplementation in either cell line (Fig. 5C ). However, the protein level of SQSTM1 was induced in both cell lines even though the autophagic flux remained unaffected for the time frame of the experiment (Fig. 2 and Fig. 5C ). Also, the immunoblot analysis revealed that the basal level of LC3B-II (relative to actin) was approximately 10 fold higher in the Caco-2 cells compared to the SW620 cells (Fig. 5D) . The basal level of SQSTM1 was found equal. The higher basal level of LC3B-II was not due to a blockade of autophagy in the Caco-2 cells, because the level was increased even further after inhibiting lysosomal activity (Fig. 5E) . Autophagy was also quantified as incorporation of the fluorescent autophagy related probe Cyto-ID detected by flow cytometry. These analyses revealed that Caco-2 cells displayed a more than 8-fold higher intensity per cell compared to the SW620 cells (Fig. 5F ). Consistent with the immunoblot analyses, DHA did not cause any significant increase in CytoID incorporation in SW620 or Caco-2 (data not shown).
We have previously generated a double tag construct composed of mCherry fused to EGFP [30] . This fusion protein is pH sensitive, since mCherry is very pH-stable whereas EGFP is labile and loses its fluorescence in the acidic lysosomes. The double tag protein showed very different pattern distribution between SW620 and Caco-2 cells, with strong accumulation in the nucleus of Caco-2 cells. Fused to SQSTM1 it locates in cytoplasmic punctuated structures representing both protein aggregates (green and red), neutral autophagosomes (green and red) and acidified lysosomes (red only). Transient expression of the mCherry-EGFP-SQSTM1 protein clearly demonstrated a higher number of red-only structures in the Caco-2 cells compared to the SW620 cells (Fig. 6 ). In addition, the frequency of cells with more acidic structures than green structures was clearly higher in the Caco-2 cells. In response to DHA there was an increase in the number of punctuated structures that were both green and red in both cell lines. Based on size, shape and fluorescent color, many of these DHA-induced structures with tagged SQSTM1 were most likely protein aggregates. Altogether, these data show that DHA is not able to induce autophagy in these two cell lines. However, in response to DHA, there is an induction of endogenous SQSTM1 and formation of protein aggregates positive for SQSTM1. Importantly, the basal level of autophagy is higher in the Caco-2 cells compared to the SW620 cells. Collectively, these results demonstrate an inverse correlation between DHA sensitivity and basal autophagy in these colon cancer cell lines.
NFE2L2-induced stress response is not the cause of DHA-sensitivity in cancer cells
To investigate whether NFE2L2-induced stress responses are important for the effect of DHA in cancer cells, siRNA targeting NFE2L2 was used to knock down the protein in SW620 and Caco-2 cells. In both cell lines, DHA (70 and 140 mM) induces protein expression of NFE2L2 and SQSTM1 (Fig. 7A) . Targeting NFE2L2 by siRNA transfection reduced the induction of NFE2L2 by DHA (70 and 140 mM) in both cell lines (Fig. 7B) . A reduction of SQSTM1 was observed in both cell lines and the level of the autophagy biomarker LC3B-II in Caco-2 and SW620 control cells was increased after NFE2L2 down regulation, suggesting a compensatory role of increased autophagy (Fig. 7C) . The increased level of LC3B-II was not due to autophagy inhibition, since there was a clear further increase in response to lysosomal inhibition by BafA1. Down regulation of NFE2L2 did not cause an increased sensitivity for DHA in SW620 and Caco-2 cells (Fig. 7G) . Also, siRNA-mediated down regulation of SQSTM1 in Caco-2 cells did not cause increased sensitivity towards DHA even if the down regulation was very efficient (data not shown). As previously mentioned, HMOX1 is expressed in Caco-2 control cells in contrast to SW620 control cells (Fig. 7D) . However, siRNA-mediated down-regulation of HMOX1 did not affect cell growth in either cell lines (Fig. 7G) .
The level of autophagy is important for DHA-induced toxicity
To determine whether basal autophagic flux was important for the sensitivity towards DHA, ATG5 or a combination of ATG5 and ATG7 was targeted by siRNA in Caco-2 cells (Fig. 7E/F) . By combining siRNA targeting both ATG5 and ATG7, a tenfold reduction of the LC3B-II protein level was observed (Fig. 7E) presence of DHA (Fig. 7F) . DHA sensitivity in ATG5 and ATG7 knock down cells were analyzed by conventional cell counting in both SW620 and Caco-2 cells and was found to be increased in both cell lines to almost the same extent (Fig. 7G) . Importantly, in the absence of DHA, the ATG5 or ATG7 siRNA transfected cells did not grow slower than the control siRNA transfected cells. Consistent with the hypothesis that basal autophagy is important for survival during DHA exposure, increasing the autophagic flux in SW620 and Caco-2 cells, using rapamycin, reduced the DHA sensitivity ( Fig. 8A/B ). In line with these findings, we show that by inhibiting autophagy with chloroquine, an increased sensitivity towards DHA is observed in Caco-2 cells (Fig. 8C) . The protein expression level of the autophagy markers LC3B-II and/or SQSTM1 respond accordingly (Fig. 8B/C) . Collectively, these results suggest that basal autophagy is important for the DHA-sensitivity in these cancer cells.
Discussion
DHA was found to induce several autophagy-related transcripts at early time points in SW620 colon cancer cells that are growth inhibited by DHA; among these are SQSTM1 and BAG3 followed by LC3B, GABARAPL1 and ULK1. However, in SW620 cells the induced transcription of autophagy related genes did not result in a corresponding activation of autophagy, and we find a low level of autophagy both prior to and after DHA supplementation in these cells. Caco-2 cells, with higher DHA-tolerance, display a much higher basal autophagy, both in the presence and absence of DHA. The lack of increased autophagic flux in response to DHA in SW620 cells was surprising, because we have previously demonstrated a clear activation of both ER stress [14] and ROS-accumulation [12] ; processes that are well documented to cause activation of autophagy. Indicative of ER-stress, several downstream targets of PERK like ATF4 and DNA damage-inducible protein 3 (DDIT3/ CHOP), were found to be induced in SW620 cells; both ATF4 and CHOP may induce the expression of autophagy genes [14, 35] .
The increased expression of autophagy genes in the SW620 cells in response to DHA could be a sign of a transcriptionally encoded response to counteract accumulation of damaged proteins. The finding that these cancer cells do not increase the autophagic flux indicates that this transcriptional response is blocked at a translational or post-translational stage. We have previously found increased phosphorylation of eIF2α, indicative of ER-stress and shut down of general translation, as early as 3 h after DHA supplementation [14] . ER stress and release of calcium are also known to induce autophagy [17] . The eIF2α/ATF4 pathway has previously been shown to mediate gene transcriptional activation of several autophagy genes in response to both amino acid starvation and ER-stress [36] . Further research is necessary to clarify the mechanisms by which eIF2α phosphorylation regulates autophagy in response to ER stress signals.
ROS may regulate autophagy both by transcriptional regulatory mechanisms and post-translational modifications. Increased levels of ROS-induced stress response activates hypoxia inducible factor 1 (HIF-1), p53, forkhead box O3 (FOXO3) and NFE2L2 which then induce transcription of LC3B, BNIP3 and SQSTM1 [37] . Also, downstream targets of the ER stress sensor PERK induce expression of autophagy genes (LC3 and ATG5) thereby increasing autophagic flux [37] . We find that SQSTM1 (3 h), NFE2L2 (6 h) BNIP3 (12 h) and FOXO3A (12 h) are induced after DHA supplementation in the SW620 cells, indicating that the transcriptional machinery of autophagy is active in these cells. ROS have also been suggested to induce autophagy by directly controlling the enzymatic activity of ATG4 needed for maturation of LC3-family members and formation of LC3B-II-positive autophagosomes [18] . In addition, it was recently reported that ROS cause an AMP-dependent activation of AMPK [38] . This kinase is crucial for the control of autophagy. ULK1 is phosphorylated and activated by AMPK [39] , and AMPK also inhibits mTOR to increase autophagic flux [15] . DHA-induced transcription of several autophagy-related genes may possibly act in concert with ROS-induced activation of AMPK, thereby causing a posttranslational activation of autophagy by increased ULK1 activity. In line with this notion, Jing et al. recently demonstrated that DHA causes an AMPK-dependent activation of autophagy in human cervical cancer SiHa cells [40] . This increased autophagy is suggested to contribute to increased cytotoxicity in a wild type p53 dependent manner. We find however the difference in DHA-sensitivity to be independent of wild type p53, since both Caco-2 and SW620 cells lack wild-type p53 [41] . Amino acid starvation of SW620 cells shows that autophagy is inducible in these cells. However, we still do not know why there are no detectable activation of autophagy in the SW620 cells after DHA-induced ROS and activation of autophagy-related genes. Niso-Santano et al. recently published the unexpected finding that unsaturated fatty acids promote autophagy in a beclin 1-(BECN1) and phosphatidylinositol 3-kinase, class 3-independent (PIK3C3) manner that is accompanied by the redistribution of LC3B to Golgi-associated vesicles, thereby relying on an intact Golgi apparatus [42] . This remains to be elucidated in our systems.
A study by Shin et al. show that supplementation of prostate cancer cell lines harboring mutant p53 with DHA results in generation of mitochondrial ROS and increased autophagic flux, suggesting that DHA induces both autophagy and apoptosis in these cells [43] . In contrast to these results, we find that both SW620 and Caco-2 cells harboring mutant p53 predicted to be damaging or non-functional [41] , do not increase autophagic flux in response to DHA. Why certain cancer cells are unable to accelerate autophagy in response to stressful situations and how common this feature is, is not known. However, mutations in the autophagy gene Beclin1 are commonly found in cancers [44, 45] . Furthermore, negative regulators of autophagy, such as PI3K and AKT are established oncogenes, and vice versa, positive regulators of the process, such as PTEN and TSC1/TSC2 are tumor suppressors [16] . Mutations in these genes may contribute to an inability to accelerate autophagy upon exposure to stress. Whether this is the case for SW620 or Caco-2 cells remains to be elucidated. Regardless, as autophagy is not induced by DHA in either cell line, we find that the basal autophagy is a determinant as to whether the cells survive DHA exposure.
The three most commonly mutated oncogenes in colorectal cancer cells are KRAS, BRAF and PI3KCA [46] . Caco-2 cells harbor no mutations in these oncogenes, while SW620 cells harbor KRAS mutation. The signaling pathways RAS/PKA and RAS/ERK have been shown to be involved in the regulation of autophagy [47] and many cancer cell lines harboring RAS mutations have also been shown to have high levels of autophagy [48] . There is a strong relationship between KRAS mutation and the NF-κB signaling pathway. SW620 cells have a constitutive activation of NF-κB in contrast to Caco-2 cells, and when treating both cell lines with a NF-κB inhibitor, the proliferation of SW620 cells was significantly decreased while the proliferation of Caco-2 cells was unaffected [49] . We have previously shown that DHA-treatment (70 mM) reduces total protein level of NF-κB in SW620 cells [35] . The role of KRAS mutation and NF-κB signaling in the regulation of autophagy remains to be elucidated in our system. SW620 cells demonstrate a robust production of ROS in response to DHA at early time points, whereas a significant increase in ROS measured as MDA was detected in Caco-2 cells after supplementation with DHA for 72 h. Vitamin E did not counteract DHA-induced ROS as measured in our systems and did not interfere with nuclear translocation of NFE2L2 in SW620 cells. Also, vitamin E was not able to restore cell growth, indicating that lipid peroxidation may not be the major cause of DHA-induced cytotoxicity in SW620 cells. In contrast, vitamin E was able to reduce the level of MDA in Caco-2 cells, but not below that in control cultures. Cancer cells may display differences in the antioxidant defense systems or differences in the metabolic pathways for PUFAs that may explain these observations. HMOX-1, well known to be induced by a variety of stress stimuli, may contribute to the cells antioxidant defense against stress induced by ROS and thereby their sensitivity towards DHA. Therefore, it is interesting that HMOX1 was expressed in Caco-2 control cells and not in the DHA-sensitive SW620 control cells. However, knock-down of HMOX1 did not affect DHA-sensitivity of either cell lines, indicating that this is a more general stress indicator.
DHA has previously been found to induce ROS-dependent aggregation and autophagic destruction of misfolded apolipoprotein B in hepatocytes [50] . Our findings suggest that DHA induces oxidative stress that may result in protein damage. The results from the double tag experiments demonstrated increased levels of protein aggregates positive for SQSTM1 in response to DHA. The rapid production of ROS and activation of NFE2L2 suggest increased ROS as an early response to PUFAs in SW620 cells. Subsequently, this ROS increase could contribute to protein misfolding and ER stress [51] . A close connection between these stress conditions is also illustrated by the important role of NFE2L2 in cell survival after ER stress [52] . However, it is difficult to separate these two intertwined stress conditions, and we have currently no firm data that demonstrate which controls the other upon DHA exposure.
Addition of DHA was found to cause a rapid stabilization and nuclear translocation of NFE2L2 in both SW620 and Caco-2 cells. In spite of this, we observed only a small increase (not significant) in ROS for the superoxide probe after prolonged exposure in the Caco-2 cells. NFE2L2 activation is negatively regulated by KEAP1. The cellular level of KEAP1 was recently shown to be controlled by autophagy; SQSTM1 makes a direct interaction and targets KEAP1 for lysosomal destruction [31, 32] . Thus, in cells with a high level of SQSTM1 and autophagy, KEAP1 is rapidly degraded leading to activation of NFE2L2. In line with this, we found the basal level of KEAP1 to be lower in Caco-2 cells compared to SW620 cells. Importantly, the affinity of SQSTM1 for KEAP1 was recently shown to be regulated by phosphorylation of SQSTM1 [53] . This phosphorylation of SQSTM1 and the resulting activation of NFE2L2 were found to be induced by diverse cellular stress conditions including arsenate and mitochondrial inhibition and to be rapamycin sensitive. As mentioned earlier, NFE2L2 is also regulated by phosphorylation by PERK after ER stress [28] . The stabilization and nuclear translocation of NFE2L2 could therefore be mediated by such an alternative mechanism in response to DHA.
Several age-related diseases are associated with elevated levels of damaged mitochondria and protein aggregates [54, 55] . Stimulation of autophagy leads to reduced accumulation of such dysfunctional cellular components [56] . Autophagy acts pro-survival by clearing cells for damaged components and may thereby mobilize a disease preventive effect. This is in line with our findings showing that stimulation or inhibition of autophagy by rapamycin or chloroquine respectively, affects the DHA-induced toxicity in our system. Our data suggest that in cancer cells where the autophagy response may be defective or down regulated, DHA may cause growth retardation and/or cell death.
The frequency of tumors composed of cancer cells with downregulated or loss of autophagy is currently not known. Unfortunately, there are currently limited possibilities to determine the actual autophagic flux in clinical samples of solid tumors, and the understanding of the role of autophagy in cancer development is still incomplete.
To test if the autophagic flux is affected after DHA supplementation in vivo, biomarkers that allow quantification of autophagy in clinical samples are needed. With such, we can evaluate if and how the process might change in response to intake of n À 3 PUFAs in both normal and cancer cells. Development of diagnostic tools of autophagy and autophagy regulators is also needed in order to test the hypothesis that cancer cells with loss of autophagy could be sensitive for DHA in clinical settings.
